Identification of MTMR2 as an AML-associated candidate biomarker derived from lipid metabolism–related transcriptomic analysis - Top-Institutions - MDSpire

Identification of MTMR2 as an AML-associated candidate biomarker derived from lipid metabolism–related transcriptomic analysis

  • By

  • Chenchen Liu

  • Yueyuan Pan

  • Minggui Chen

  • Songyu Li

  • Chong Zhang

  • May 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Hematology
    • Oncology

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Hematology
    • Oncology

Original Source(s)

Identification of MTMR2 as an AML-associated candidate biomarker derived from lipid metabolism–related transcriptomic analysis

  • by Chenchen Liu, Yueyuan Pan, Minggui Chen, Songyu Li, Chong Zhang

  • May 29, 2026

Related Content

MRI-guided risk stratification for neoadjuvant immunotherapy in rectal cancer

Management of toxicities from antibody – drug conjugates in breast cancer

Diagnostic efficacy of ultrasound combined with fine-needle aspiration biopsy for papillary thyroid carcinoma based on C-TIRADS and ATA guidelines